DOJ, SEC Reach Deal In Drug Maker's Insider-Trading
Federal prosecutors and securities regulators have wrapped up parallel cases against a former executive at bankrupt generic drug maker Able Laboratories Inc., after accusing him of insider-trading in a scheme to...To view the full article, register now.
Already a subscriber? Click here to view full article